Skip to main content
padlock icon - secure page this page is secure

Free Content Long‐Term Results of Biopsy‐Guided Selection and Allocation of Kidneys From Older Donors in Older Recipients

Download Article:

You have access to the full text article on a website external to Ingenta Connect.

Please click here to view this article on Wiley Online Library.

You may be required to register and activate access on Wiley Online Library before you can obtain the full text. If you have any queries please visit Wiley Online Library

In our old‐for‐old program, we discard or allocate older extended criteria donor kidneys to single (SKT) or dual kidney transplantation (DKT) depending on histological Remuzzi's score in recipients older than 60 years. Here, we analyze the long‐term results of this program and try to identify independent predictors of patient and graft survival. Between December 1996 and January 2008, we performed 115 SKT and 88 DKT. Discard rate was 15%. Acute rejection incidence was higher in SKT than in DKT (22.6% vs. 11.4%, p = 0.04). Renal function was better in DKT than in SKT up to 5 years after transplantation. Surgical complications were frequent in DKT. Ten‐year cumulative graft survival was significantly lower in the SKT group (31% vs. 53%, p = 0.03). In SKT, histological score 4 provided similar graft survival than 3 or less, whereas in DKT score 4, 5 or 6 displayed similar outcome. Finally, independent predictors of graft survival were history of major adverse cardiac event and 1‐year serum creatinine, rather than SKT or DKT. In conclusion, this biopsy‐guided old‐for‐old strategy resulted in acceptable long‐term graft survival. Our results suggest that DKT should be considered for scores of 5 or 6 only.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Document Type: Research Article

Affiliations: 1: Nephrology Department, Hospital Universitari Germans Trias i Pujol, Badalona, Spain 2: Urology Department 3: Nephrology Department 4: Pathology Department, Hospital Universitari de Bellvitge, IDIBELL, L’Hospitalet de Llobregat, Barcelona, Spain 5: Central Unit of Clinical Research and Clinical Trials (UCICEC-CAIBER), IDIBELL, L’Hospitalet de Llobregat, Barcelona, Spain

Publication date: October 1, 2012

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more